UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000021129
Receipt No. R000024259
Scientific Title A multi-center, randomized controlled trial comparing early versus elective colonoscopy in outpatients with acute lower gastrointestinal bleeding
Date of disclosure of the study information 2016/02/21
Last modified on 2019/09/24 (Ver. 16)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title A multi-center, randomized controlled trial comparing early versus elective colonoscopy in outpatients with acute lower gastrointestinal bleeding
Acronym Early colonoscopy trial
Scientific Title A multi-center, randomized controlled trial comparing early versus elective colonoscopy in outpatients with acute lower gastrointestinal bleeding
Scientific Title:Acronym Early colonoscopy trial
Region
Japan

Condition
Condition Acute lower gastrointestinal bleeding
Classification by specialty
Gastroenterology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To evaluate stigmata recent of hemorrhage rate of early versus elective colonoscopy in outpatient with acute lower gastrointestinal bleeding.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2
Developmental phase Phase III

Assessment
Primary outcomes Stigmata recent of hemorrhage rate in lower gastrointestinal tract
Key secondary outcomes Success rate of endoscopic treatment, need for additional endoscopic examination, need for interventional radiology, need for surgery, 30 day rebleeding rates, length of stay, 30 day thrombosis events, 30 day mortality, preparation related adverse events (nausea, vomitting, abdominal pain, volume overload, aspiration pnumonia, hemorrhagic shock, exacerbation bleeding, and ileus), and colonoscopy related adverse events (hemorrhagic shock, and perforation).

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control Active
Stratification NO
Dynamic allocation NO
Institution consideration Institution is not considered as adjustment factor.
Blocking YES
Concealment Central registration

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Maneuver
Interventions/Control_1 Early colonoscopy: performing prepared
colonoscopy within 24 h on arrival.
Interventions/Control_2 Elective colonoscopy: performing prepared colonoscopy between 24 and 96 h on arrival.
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Inclusion criteria
1.Adults aged>=20 years presenting
moderate to severe hematochezia or melena
within 24 h on arrival, defined as (i) more than 3 bloody bowel movements within 8 h; (ii)
hemorrhagic shock; or (iii) requiring
transfusion.
2.All patients were able to provide informed
consent.
Key exclusion criteria Exclusion criteria
1.Patients with hematemesis, black vomiting, or melena.
2.Upper gastrointestinal bleeding patients who diagnosed by nasogastric tube or upper endoscopy.
3.Patients who had impossible consumed the oral bowel preparation solution.
4.Patients who received computed tomography.
5.Patients who diagnosed peptic ulcer diseases within 10 days.
6.Ulcerative colitis, or Crohn diseases patients.
7.Patients who received abdominal surgery.
8.Patients who received polypectomy, endoscopic mucosal resection, or endoscopic submucosal dissection of the colon within 10 days.
9.Patients with suspected perforation, or peritonitis.
10.Patients with suspected intestinal obstruction.
11.Patients with hemorrhagic shock refractory to infusion or blood transfusion.
12.Patients who received total colectomy.
13.Patients with suspected disseminated intravascular coagulation.
14.Patients with end stage malignant disease.
15.Patients with severe cardiac failure.
16.Patients with active thrombosis.
17.Patients with severe respiratory failure.
18.Pregnant patients.
Target sample size 162

Research contact person
Name of lead principal investigator
1st name Atsuo
Middle name
Last name Yamada
Organization Graduate School of Medicine, The University of Tokyo
Division name Department of Gastroenterology
Zip code 1138655
Address 7-3-1 Hongo, Bunkyo-ku, Tokyo
TEL 03-3815-5411
Email yamada-a@umin.ac.jp

Public contact
Name of contact person
1st name Ryota
Middle name
Last name Niikua
Organization Graduate School of Medicine, The University of Tokyo
Division name Department of Gastroenterology
Zip code 1138655
Address 7-3-1 Hongo, Bunkyo-ku, Tokyo
TEL 03-3815-5411
Homepage URL
Email rniikura@triton.ocn.ne.jp

Sponsor
Institute Graduate School of Medicine, The University of Tokyo
Institute
Department

Funding Source
Organization The Japanese Gastroenterological Association
Organization
Division
Category of Funding Organization Non profit foundation
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization The University of Tokyo, Clinical Research Review Board
Address 7-3-1, Hongo, Bunkyo-ku, Tokyo
Tel 03-5800-8743
Email crctky-office@umin.ac.jp

Secondary IDs
Secondary IDs YES
Study ID_1 NCT 03098173
Org. issuing International ID_1 ClinicalTrials.gov
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 東京大学医学部附属病院 
国立国際医療研究センター病院
石川県立中央病院
聖路加国際病院 
国立国際医療研究センター国府台病院
小樽掖済会病院 
市立豊中病院
国立病院機構函館病院
斗南病院
福井県立病院
弘前大学医学部附属病院
愛知県がんセンター
長崎みなとメディカルセンター市民病院
周東総合病院
地域医療機能推進機構大阪病院

Other administrative information
Date of disclosure of the study information
2016 Year 02 Month 21 Day

Related information
URL releasing protocol http://www.todai-shoukakan.com/cont4/29.html
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2016 Year 01 Month 29 Day
Date of IRB
2016 Year 01 Month 21 Day
Anticipated trial start date
2016 Year 07 Month 13 Day
Last follow-up date
2018 Year 06 Month 26 Day
Date of closure to data entry
2018 Year 06 Month 26 Day
Date trial data considered complete
2018 Year 08 Month 24 Day
Date analysis concluded
2018 Year 11 Month 01 Day

Other
Other related information

Management information
Registered date
2016 Year 02 Month 21 Day
Last modified on
2019 Year 09 Month 24 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024259